关注
Siddhant Palekar
Siddhant Palekar
Product Development Scientist, Aprecia Pharmaceuticals
在 stjohns.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Application of 3D printing technology and quality by design approach for development of age-appropriate pediatric formulation of baclofen
S Palekar, PK Nukala, SM Mishra, T Kipping, K Patel
International journal of pharmaceutics 556, 106-116, 2019
1782019
Abuse deterrent immediate release egg-shaped tablet (Egglets) using 3D printing technology: quality by design to optimize drug release and extraction
PK Nukala, S Palekar, M Patki, K Patel
Aaps Pharmscitech 20, 1-12, 2019
1002019
Investigating the application of FDM 3D printing pattern in preparation of patient-tailored dosage forms
PK Nukala, S Palekar, N Solanki, Y Fu, M Patki, AA Shohatee, ...
Journal of 3D printing in medicine 3 (1), 23-37, 2019
582019
Process optimization of twin-screw melt granulation of fenofibrate using design of experiment (DoE)
HK Mamidi, S Palekar, PK Nukala, SM Mishra, M Patki, Y Fu, P Supner, ...
International Journal of Pharmaceutics 593, 120101, 2021
362021
Multi-dose oral abuse deterrent formulation of loperamide using hot melt extrusion
PK Nukala, S Palekar, M Patki, Y Fu, K Patel
International journal of pharmaceutics 569, 118629, 2019
292019
Nanocrystals for controlled delivery: state of the art and approved drug products
RS Kalhapure, S Palekar, K Patel, J Monpara
Expert opinion on drug delivery 19 (10), 1303-1316, 2022
192022
Self-injectable extended release formulation of Remdesivir (SelfExRem): A potential formulation alternative for COVID-19 treatment
M Patki, S Palekar, S Reznik, K Patel
International Journal of Pharmaceutics 597, 120329, 2021
172021
Aversion liquid-filled drug releasing capsule (3D-RECAL): A novel technology for the development of immediate release abuse deterrent formulations using a fused deposition …
S Palekar, PK Nukala, K Patel
International Journal of Pharmaceutics 621, 121804, 2022
142022
Ibrutinib amorphous solid dispersions with enhanced dissolution at colonic pH for the localized treatment of colorectal cancer
H Patel, S Palekar, A Patel, K Patel
International Journal of Pharmaceutics 641, 123056, 2023
122023
Abuse deterrent immediate release film technology (ADRIFT): A novel bilayer film technology for limiting intentional drug abuse
S Palekar, PK Nukala, R Vartak, K Patel
International Journal of Pharmaceutics 590, 119944, 2020
122020
Overdose and alcohol sensitive immediate release system (OASIS) for deterring accidental overdose or abuse of drugs
M Patki, S Palekar, PK Nukala, R Vartak, K Patel
Aaps Pharmscitech 22, 1-12, 2021
102021
Tunable Drug Release from Fused Deposition Modelling (FDM) 3D-Printed Tablets Fabricated Using a Novel Extrudable Polymer
V Raje, S Palekar, S Banella, K Patel
Pharmaceutics 14 (10), 2192, 2022
92022
Development of a safe pediatric liquisolid self-nanoemulsifying system of triclabendazole for the treatment of fascioliasis
S Daware, M Patki, A Saraswat, S Palekar, K Patel
International Journal of Pharmaceutics 626, 122163, 2022
82022
Corroborating various material-sparing techniques with hot melt extrusion for the preparation of triclabendazole amorphous solid dispersions
S Palekar, HK Mamidi, Y Guo, R Vartak, K Patel
International Journal of Pharmaceutics 640, 122989, 2023
72023
Formulation strategies for the development of high drug-loaded amorphous solid dispersions
H Mamidi, S Palekar, H Patel, PK Nukala, K Patel
Drug Discovery Today, 103806, 2023
12023
Tunable drug release from fused deposition modelling (FDM) 3D-printed tablets fabricated using a novel extrudable polymer. Pharmaceutics. 2022; 14: 2192. MDPI
V Raje, S Palekar, S Banella, K Patel
s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2022
12022
系统目前无法执行此操作,请稍后再试。
文章 1–16